摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-methyl[1,4]thiazine-2,5-dione

中文名称
——
中文别名
——
英文名称
6-methyl[1,4]thiazine-2,5-dione
英文别名
6-methyl-1,4-thiazine-2,5-dione
6-methyl[1,4]thiazine-2,5-dione化学式
CAS
——
化学式
C5H5NO2S
mdl
——
分子量
143.166
InChiKey
TZMCHPNMORUCEV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    71.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    硫普罗宁氯甲酸乙酯二氯甲烷三乙胺 为溶剂, 以30%的产率得到6-methyl[1,4]thiazine-2,5-dione
    参考文献:
    名称:
    Antihypertensive 1,4-thiazepine-ones, 1,4-thiazonine-ones, and method of
    摘要:
    结构为##STR1##的降压化合物,其中:n是从0到2的整数,包括R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6和R.sub.7独立地为氢、具有1至6个碳原子的烷基、具有2至6个碳原子的烯基、具有2至6个碳原子的炔基、具有3至16个碳原子的环烷基、苯基、苄基、甲苯基、萘基、苯乙基、茚基、四氢萘基、十氢萘基、吡啶基、喹啉基、吡咯啉基、吡咯基、吗啉基、硫代吗啉基、呋喃基、呋喃基、四氢呋喃基、苯并咪唑基、噻吩基、咪唑基或四氢吲啶基,且R.sub.1到R.sub.7基团为烷基时,该基团携带从羟基、烷氧基、氨基、羧基或羰基中选择的取代基,烷氧基和羰基中的烷基基团具有1至6个碳原子,或者R.sub.2与R.sub.3及它们连接的碳一起形成四氢萘基或苯基,当苯基R.sub.1和R.sub.4缺失时,或者R.sub.6和R.sub.7与R.sub.6连接的碳和R.sub.7连接的氮一起形成从吡咯基、噻唑啉、四氢异喹啉、硫代吗啉或2,2,5,5-四甲基噻唑啉中选择的杂环,Y为.dbd.O、.dbd.S、.dbd.NR.sub.1、.dbd.NOR.sub.1或.dbd.N--NH.sub.2,其中R.sub.1与上述定义相同。
    公开号:
    US04287203A1
点击查看最新优质反应信息

文献信息

  • Antihypertensive lactams
    申请人:——
    公开号:US04766210A1
    公开(公告)日:1988-08-23
    Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 are independently hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 2 to 6 carbon atoms, alkynyl having from 2 to 6 carbon atoms, cycloalkyl having from 3 to 16 carbon atoms, phenyl, benzyl, tolyl, naphthyl, phenethyl, indanyl, tetrahydronaphthyl, decahydronaphthyl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, morpholinyl, thiomorpholinyl, furyl, furfuryl, tetrahydrofurfuryl, benzimidazole, thienyl, imidolyl, or tetrahydroindolyl, and where the R.sub.1 to R.sub.7 groups are alkyl, said groups carrying a substituent selected from hydroxy, alkoxy, amino, carboxy, or carbalkoxy, the alkyl group in alkoxy and carbalkoxy having from 1 to 6 carbon atoms, or R.sub.2 taken together with R.sub.3 and the carbons to which they are attached is tetrahydronapthyl or phenyl, and when phenyl R.sub.1 and R.sub.4 are absent, or R.sub.6 and R.sub.7 taken together with the carbon to which R.sub.6 is attached and the nitrogen to which R.sub.7 is attached form a heterocycle selected from pyrrolidyl, thiazolidine, tetrahydro-isoquinoline, thiomorpholine, or 2,2,5,5-tetramethylthiazolidinie, and Y is .dbd.O, .dbd.S, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.
    结构式为##STR1##的降压化合物,其中:n是0至2的整数,R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6和R.sub.7独立地为氢、碳数为1到6的烷基、碳数为2到6的烯基、碳数为2到6的炔基、碳数为3到16的环烷基、苯基、苄基、甲苯基、萘基、苯乙基、茚基、四氢萘基、十氢萘基、吡啶基、喹啉基、吡咯烷基、吡咯基、吗啉基、硫代吗啉基、呋喃基、呋喃甲基、四氢呋喃基、苯并咪唑基、噻吩基、咪唑基或四氢吲哚基,其中R.sub.1至R.sub.7基为烷基,所述基带有从羟基、烷氧基、氨基、羧基或羧烷氧基中选择的取代基,烷氧基和羧烷氧基中的烷基含有1到6个碳原子,或R.sub.2与R.sub.3及它们所连接的碳一起取代为四氢萘基或苯基,当苯基R.sub.1和R.sub.4不存在时,或R.sub.6和R.sub.7与R.sub.6所连接的碳和R.sub.7所连接的氮一起形成从吡咯基、噻唑环、四氢异喹啉、硫代吗啉或2,2,5,5-四甲基噻唑环中选择的杂环,且Y为.dbd.O、.dbd.S、.dbd.NR.sub.1、.dbd.NOR.sub.1或.dbd.N--NH.sub.2,其中R.sub.1与上述定义相同。
  • Antihypertensive 1,4-thiazepine-ones, 1,4-thiazonine-ones, and method of
    申请人:USV Pharmaceutical Corporation
    公开号:US04287203A1
    公开(公告)日:1981-09-01
    Antihypertensive compounds of the structure ##STR1## wherein: n is an integer from 0 to 2 inclusive, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, and R.sub.7 are independently hydrogen, alkyl having from 1 to 6 carbon atoms, alkenyl having from 2 to 6 carbon atoms, alkynyl having from 2 to 6 carbon atoms, cycloalkyl having from 3 to 16 carbon atoms, phenyl, benzyl, tolyl, naphthyl, phenethyl, indanyl, tetrahydronaphthyl, decanydronaphthyl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, morpholinyl, thiomorpholinyl, furyl, furfuryl, tetrahydrofurfuryl, benzimidazole, thienyl, imidolyl, or tetrahydroindolyl, and where the R.sub.1 to R.sub.7 groups are alkyl, said groups carrying a substituent selected from hydroxy, alkoxy, amino, carboxy, or carbalkoxy, the alkyl group in alkoxy and carbalkoxy having from 1 to 6 carbon atoms, or R.sub.2 taken together with R.sub.3 and the carbons to which they are attached is tetrahydronaphthyl or phenyl, and when phenyl R.sub.1 and R.sub.4 are absent, or R.sub.6 and R.sub.7 taken together with the carbon to which R.sub.6 is attached and the nitrogen to which R.sub.7 is attached form a heterocycle selected from pyrrolidyl, thiazolidine, tetrahydro-isoquinoline, thiomorpholine, or 2,2,5,5-tetramethylthiazolidinie, and Y is .dbd.O, .dbd.S, .dbd.NR.sub.1, .dbd.NOR.sub.1 or .dbd.N--NH.sub.2, R.sub.1 being the same as defined above.
    结构为##STR1##的降压化合物,其中:n是从0到2的整数,包括R.sub.1、R.sub.2、R.sub.3、R.sub.4、R.sub.5、R.sub.6和R.sub.7独立地为氢、具有1至6个碳原子的烷基、具有2至6个碳原子的烯基、具有2至6个碳原子的炔基、具有3至16个碳原子的环烷基、苯基、苄基、甲苯基、萘基、苯乙基、茚基、四氢萘基、十氢萘基、吡啶基、喹啉基、吡咯啉基、吡咯基、吗啉基、硫代吗啉基、呋喃基、呋喃基、四氢呋喃基、苯并咪唑基、噻吩基、咪唑基或四氢吲啶基,且R.sub.1到R.sub.7基团为烷基时,该基团携带从羟基、烷氧基、氨基、羧基或羰基中选择的取代基,烷氧基和羰基中的烷基基团具有1至6个碳原子,或者R.sub.2与R.sub.3及它们连接的碳一起形成四氢萘基或苯基,当苯基R.sub.1和R.sub.4缺失时,或者R.sub.6和R.sub.7与R.sub.6连接的碳和R.sub.7连接的氮一起形成从吡咯基、噻唑啉、四氢异喹啉、硫代吗啉或2,2,5,5-四甲基噻唑啉中选择的杂环,Y为.dbd.O、.dbd.S、.dbd.NR.sub.1、.dbd.NOR.sub.1或.dbd.N--NH.sub.2,其中R.sub.1与上述定义相同。
查看更多

同类化合物

6-methyl[1,4]thiazine-2,5-dione 3,6,9,12,22,25,28,31-Octathiaheptacyclo[31.5.1.11,35.114,18.114,20.116,20.133,37]tetratetracontane-2,13,21,32-tetrone 3,6,9,12,15,25,28,31,34,37-Decathiaheptacyclo[37.5.1.11,41.117,21.117,23.119,23.139,43]pentacontane-2,16,24,38-tetrone Thio-exaltolide 1,5,11,15-Tetrathia-cycloicosane-6,10,16,20-tetraone 1,5,12,16-Tetrathia-cyclodocosane-6,11,17,22-tetraone 1,5-Dithia-cycloundecane-6,11-dione 3,6,9,12-tetrathia-1(1,3)-adamantanacyclotridecaphane-2,13-dione 3,6,9,13,16,19,23,26,29-nonathia-1,11,21(1,3)-triadamantanacyclotriacontaphane-2,10,12,20,22,30-hexaone 3,6,9,13,16,19-hexathia-1,11(1,3)-diadamantanacycloicosaphane-2,10,12,20-tetraone 3,6,9,12,15-pentathia-1(1,3)-adamantanacyclohexadecaphane-2,16-dione (3S,4S)-3-allyl-4-tert-butylcarbonylthietan-2-one (3S,4R)-3-allyl-4-tert-butylcarbonylthietan-2-one 2,5,8,11-tetrathiacyclopentadecane-1,12-dione 1,4,10,13-tetrathiacyclooctadecane-5,9,14,18-tetrone 3,6,10,13,17,20-hexathia-1,8,15(1,3)-triadamantanacyclohenicosaphane-2,7,9,14,16,21-hexaone 3,6,10,13-tetrathia-1,8(1,3)-diadamantanacyclotetradecaphane-2,7,9,14-tetraone 3,8-Dihydro-2H-thiocin-2-one 3-methylidene-1,5,9-trithiacyclopentadecane-2,8-dione 1,4,10,13,16-hexathiacyclooctadecane-2,3,11,12-tetraone 2H-Thiocin-2-one, 3,8-dihydro- 1,4-dithiacyclotridecane-5,13-dione thioundecanolide 2-(ethoxycarbonyl)-2-methyl-β-propiothiolactone 2,2-dimethyl-β-propiothiolactone 10-(Hydroxymethyl)-3,4,7,8,9,10-hexahydro-2H-thiecin-2-one 2,2-dichloro-1-methyl-4,7-dithiabicyclo<6.2.1>undec-8(11)-en-3-one Dispironona-3,8-dien)>-4'-one 3-methyl-1,4-dithiepan-2-one 1,4,7-Trioxa-10,15-dithia-cycloheptadecane-11,14-dione 2,2-Dichloro-3-methyl-(E)-4-nonene-9-thiolide β,β-dimethyl-β-propiothiolactone 1,4,11,14-Tetrathiacycloicosane-5,10,15,20-tetrone 1,4-dithiacycloundecane-5,11-dione 1,4,12,15-tetrathiacyclodocosane-5,11,16,22-tetrone 1,5-Dithiacyclododecane-6,12-dione 4-(3-Butenyl) Thiacyclobutan-2-on 3-(4-oxo-pentyl)-[1,4]dithiepan-2-one 3,4,4-trimethyl-2-oxothietan-3-yl acetate α-Methyl-β-propiothiolactone 4-methylthiethanone 1-Thia-6-azaspiro[3.3]heptane-2,3-dione;2,2,2-trifluoroacetic acid Methyl 2-(6-oxo-2,3-dihydro-1,4-thiazin-5-yl)acetate 17,28-Dioxo-1,8,9,16-tetrathiacyclooctacosane methyl (3S)-3-methyl-2-oxothietane-3-carboxylate methyl (3R)-3-methyl-2-oxothietane-3-carboxylate 1-Thiacyclohexadec-13-en-2-one 1,8-Dithiacyclooctadecane-2,7-dione 9,20-Dioxo-1,8-dithiacycloeicosane 2-thiaspiro[3.5]nonan-1-one